The age at onset of rheumatoid arthritis is increasing in Japan: a nationwide database study

Eri Kato1, Tetsuji Sawada1, Koichiro Tahara1

  • 1Department of Rheumatology, Tokyo Medical University Hospital, Tokyo, Japan.

Insights

The average age of rheumatoid arthritis (RA) onset in Japan has significantly increased over the past decade, likely due to an aging population and potential environmental factors influencing baby boomers.

Area of Science:

  • Rheumatology
  • Epidemiology
  • Gerontology

Background:

  • Rheumatoid arthritis (RA) is a chronic autoimmune disease affecting joints.
  • Understanding trends in RA onset age is crucial for public health planning and resource allocation.
  • Japan's demographic shifts, including an aging population, may influence disease patterns.

Purpose of the Study:

  • To investigate changes in the age at onset of rheumatoid arthritis (RA) in Japan.
  • To analyze RA onset trends using a nationwide Japanese database.
  • To identify potential demographic and environmental factors associated with observed changes.

Main Methods:

  • Analysis of early RA patient data registered in the NinJa database in 2003, 2008, and 2013.
  • Comparison of mean age at RA onset across different time periods.
  • Examination of RA prevalence across age groups, including the 'baby boomer' generation.

Main Results:

  • The mean age at RA onset in Japan increased significantly from 55.8 years (2002-2003) to 59.9 years (2012-2013).
  • The peak age group for RA onset shifted from 50-59 years to 60-69 years over the study period.
  • RA prevalence was notably higher in the 50-59 age group during 2002-2003, coinciding with the first baby boomers.

Conclusions:

  • The age at RA onset in Japan has demonstrably increased over the last decade.
  • Japan's aging population is a primary factor contributing to the rising age of RA onset.
  • Environmental factors may also play a role, particularly for the baby boomer generation, in the observed increase in RA onset age.
Abstract

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
699
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
842
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
16.2K
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
436
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.5K
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
400